Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Operating Expenses (2018 - 2019)

Historic Operating Expenses for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $2.8 million.

  • DiaMedica Therapeutics' Operating Expenses rose 3084.55% to $2.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $11.6 million, marking a year-over-year increase of 5968.32%. This contributed to the annual value of $26.7 million for FY2024, which is 2545.73% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Operating Expenses of $2.8 million as of Q4 2019, which was up 3084.55% from $2.7 million recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Operating Expenses registered a high of $3.4 million during Q1 2019, and its lowest value of $1.3 million during Q1 2018.